Drugs / Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03180034 Background | Nov 2017 → Aug 2025 overdue | cervical carcinoma, human papilloma virus infection | National Cancer Institute (NCI) | Active not recruiting | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03180034 ↗ |
| Modality | Vaccine | “Biological: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed” NCT03180034 ↗ |
| Route | Intramuscular | “Given IM” NCT03180034 ↗ |